on 10 Jan 2023
Last Applicant/ Owned by
Parkville VIC 3052
AU
Serial Number
79336602 filed on 04th Oct 2021
Registration Number
6945376 registered on 10th Jan 2023
Filing Basis
No Filing Basis
Disclaimer
NO DATA
The mark consists of of the wording IMMULAB, with two dots over the letter I in blue, with LAB in blue, and with IMMU in gray. To the right is a black, gray, and blue butterfly. Pharmaceutical preparations and substances, namely, blood grouping serums and blood typing serums, namely, medical reagents and assays for testing blood to determine blood type; blood components for medical purposes, name Read More
Chemical and biological reagents for non-medical purposes; chemical test kits comprised of chemical preparations for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for scientific and/or industrial purposes; diagnostic and chemical reagents for testing for scientific and research purposes; chemical and biological reagents for non-medical purposes; chemical and biological reagents for anti-body screening, blood grouping, and for the typing and detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes, all the aforesaid being for scientific and research purposes; chemical test kits for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for anti-body screening, blood grouping, and the typing and detection of specific blood cells for scientific and research purposes
Pharmaceutical preparations and substances, namely, blood grouping serums and blood typing serums, namely, medical reagents and assays for testing blood to determine blood type; blood components for medical purposes, namely, platelets, plasma and red blood cells; pharmaceutical test kits in this class, being for diagnostic medical purposes, namely, diagnostic test kits comprised of medical diagnostic reagents and assays for clinical laboratory use in use in blood grouping and antibody screening; blood products for medical purposes, namely, blood plasma, reagent blood cells; reagents for medical use, namely, reagents for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes; clinical medical reagents for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes; pharmaceutical preparations, namely, reagent red blood cells used for quality control in immunohematology tests to detect antibodies or immunoglobulin subtypes; diagnostic reagents for medical or veterinary use; pharmaceutical preparations, namely, reagent red blood cells for medical use and medical testing used to detect antibodies or immunoglobulin subtypes; test kits comprised of medical diagnostic reagents and assays for testing of body fluids; chemical reagents for medical purposes; biological reagents for medical use
No 79336602
No Service/Collective Mark
No 32072-566678
No
No
No
No
No
No
No
No
01.15.25 -
Other natural phenomena and observable events
03.23.01 -
Butterflies, moths\r
26.01.21 -
Circles that are totally or partially shaded
The mark consists of of the wording IMMULAB, with two dots over the letter I in blue, with LAB in blue, and with IMMU in gray. To the right is a black, gray, and blue butterfly.
Status Date | Action Taken |
---|---|
26th Apr 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
26th Apr 2023 | FINAL DISPOSITION PROCESSED |
10th Apr 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
10th Jan 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
10th Jan 2023 | REGISTERED-PRINCIPAL REGISTER |
25th Oct 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
25th Oct 2022 | PUBLISHED FOR OPPOSITION |
05th Oct 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
19th Sep 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
26th Aug 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |